tiprankstipranks
Trending News
More News >
Vertex Pharmaceuticals Inc. (VRTX)
NASDAQ:VRTX
US Market

Vertex Pharmaceuticals (VRTX) Income Statement

Compare
6,635 Followers

Vertex Pharmaceuticals Income Statement

Last quarter (Q4 2025), Vertex Pharmaceuticals's total revenue was $3.23B, an increase of 10.82% from the same quarter last year. In Q4, Vertex Pharmaceuticals's net income was $1.19B. See Vertex Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 12.07B$ 11.02B$ 9.87B$ 8.93B$ 7.57B
Gross Profit
$ 10.27B$ 9.49B$ 8.61B$ 7.85B$ 6.67B
Operating Expenses
$ 5.51B$ 9.72B$ 4.78B$ 3.54B$ 3.89B
Depreciation and Amortization
$ 207.20M$ 205.80M$ 181.30M$ 148.30M$ 125.60M
EBITDA
$ 4.97B$ 486.30M$ 4.61B$ 4.44B$ 2.92B
Operating Income
$ 4.76B$ -232.90M$ 3.83B$ 4.31B$ 2.78B
Other Income/Expenses
$ -117.50M$ 481.40M$ 547.80M$ -75.00M$ -51.70M
Pretax Income
$ 4.64B$ 248.50M$ 4.38B$ 4.23B$ 2.73B
Net Income
$ 3.95B$ -535.60M$ 3.62B$ 3.32B$ 2.34B
Per Share Metrics
Basic EPS
$ 15.46$ -2.08$ 14.05$ 12.97$ 9.09
Diluted EPS
$ 15.32$ -2.08$ 13.89$ 12.82$ 9.01
Weighted Average Shares Outstanding
255.70M 257.50M 257.70M 256.10M 257.70M
Weighted Average Shares Outstanding (Diluted)
258.00M 257.90M 260.50M 259.10M 259.90M
Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History